Response of the Endogenous Antioxidant Defense System Induced in RAW 264.7 Macrophages upon Exposure to Dextran-Coated Iron Oxide Nanoparticles

Presently, iron oxide nanoparticles are the only ones approved for clinical use as contrast agents in magnetic resonance imaging (MRI). Even though there is a high demand for these types of nanoparticles both for clinical use as well as for research, there are difficulties in obtaining stable nanoparticles with reproducible properties. In this context, in this study, we report the obtaining by an adapted coprecipitation method of dextran-coated maghemite nanoparticles (ɤ-Fe2O3 NPs). The morphology and structure of the dextran-coated maghemite nanoparticles (ɤ-Fe2O3 NPs) were determined using scanning electron microscopy (SEM) and transmission electron microscopy (TEM). The TEM and SEM micrographs highlighted the obtaining of particles of nanometric size and spherical shape morphology. Furthermore, the high-resolution transmission electron microscopy (HRTEM), as well as selected area diffraction (SAED), revealed that the obtained samples presented the structure of cubic maghemite. In this study, we also explored the effects of the co-precipitation synthesized dextran-coated maghemite nanoparticles (ɤ-Fe2O3 NPs) on the redox status of macrophages. For cytotoxicity evaluation of these NPs, murine macrophages (RAW 264.7 cell line) were exposed to different concentrations of dextran-coated maghemite nanoparticles (ɤ-Fe2O3 NPs) corresponding to 0–500 μg Fe3+/mL and incubated for 24, 48, and 72 h. Intracellular iron uptake, changes in the oxidative stress parameters (reactive oxygen species production and malondialdehyde level), and the activity of antioxidant enzymes, as well as GSH concentration in cells, were evaluated after incubation with a lower (50 μg Fe3+/mL) and higher (500 μg Fe3+/mL) dose of NPs. The results indicated a significant decrease in RAW 264.7 cell viability after 72 h in the presence of NPs at concentrations above 25 μg Fe3+/mL. An important accumulation of NPs, dependent on dose and exposure time, was detected in macrophages, but it induced only a limited raise in the oxidative status. We showed here that the antioxidant capacity of RAW 264.7 macrophages was efficient in counteracting dextran-coated maghemite nanoparticles (ɤ-Fe2O3 NPs) toxicity even at higher doses.

[1]  D. Predoi,et al.  In Vitro and In Vivo Biological Assays of Dextran Coated Iron Oxide Aqueous Magnetic Fluids , 2023, Pharmaceutics.

[2]  M. Zarrelli,et al.  Functionalized Magnetite Nanoparticles: Characterization, Bioeffects, and Role of Reactive Oxygen Species in Unicellular and Enzymatic Systems , 2023, International journal of molecular sciences.

[3]  B. Sartori,et al.  Carboxymethyl-Dextran-Coated Superparamagnetic Iron Oxide Nanoparticles for Drug Delivery: Influence of the Coating Thickness on the Particle Properties , 2022, International journal of molecular sciences.

[4]  A. Khachatryan,et al.  Morphological Changes in the Oral Mucous Membrane in Viral Hepatitis C Patients: A Cross-Sectional Study , 2022, International journal of environmental research and public health.

[5]  M. Badea,et al.  Iron-Oxide-Nanoparticles-Doped Polyaniline Composite Thin Films , 2022, Polymers.

[6]  Jessica C. Hsu,et al.  Repurposing ferumoxytol: Diagnostic and therapeutic applications of an FDA-approved nanoparticle , 2022, Theranostics.

[7]  W. Strauss,et al.  Ferumoxytol for the treatment of iron deficiency and iron-deficiency anemia of pregnancy , 2021, Therapeutic advances in hematology.

[8]  P. Kalra,et al.  Newer formulations of intravenous iron: a review of their chemistry and key safety aspects – hypersensitivity, hypophosphatemia, and cardiovascular safety , 2021, Expert Opinion on Drug Safety.

[9]  G. Dzhardimalieva,et al.  Effects of Modified Magnetite Nanoparticles on Bacterial Cells and Enzyme Reactions , 2020, Nanomaterials.

[10]  D. F. Barber,et al.  The Intrinsic Biological Identities of Iron Oxide Nanoparticles and Their Coatings: Unexplored Territory for Combinatorial Therapies , 2020, Nanomaterials.

[11]  J. M. Lanao,et al.  Targeting of Hepatic Macrophages by Therapeutic Nanoparticles , 2020, Frontiers in Immunology.

[12]  H. T. Aiyelabegan,et al.  Toxicity assessment of superparamagnetic iron oxide nanoparticles in different tissues , 2020, Artificial cells, nanomedicine, and biotechnology.

[13]  A. Mukherjee,et al.  Genotoxicity and biocompatibility of superparamagnetic iron oxide nanoparticles: Influence of surface modification on biodistribution, retention, DNA damage and oxidative stress. , 2019, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[14]  L. Boscá,et al.  Self-defense of macrophages against oxidative injury: Fighting for their own survival , 2019, Redox biology.

[15]  L. Virág,et al.  PARP1‐LSD1 functional interplay controls transcription of SOD2 that protects human pro‐inflammatory macrophages from death under an oxidative condition , 2019, Free radical biology & medicine.

[16]  J. Perez,et al.  Biological Effects of Nanoparticles on Macrophage Polarization in the Tumor Microenvironment , 2019, Nanotheranostics.

[17]  A. Denicola,et al.  Diffusion and Transport of Reactive Species Across Cell Membranes. , 2019, Advances in experimental medicine and biology.

[18]  H. Rubbo,et al.  Bioactive Lipids in Health and Disease , 2019, Advances in Experimental Medicine and Biology.

[19]  R. Branicky,et al.  Superoxide dismutases: Dual roles in controlling ROS damage and regulating ROS signaling , 2018, The Journal of cell biology.

[20]  Hatice Kaplan Can,et al.  Preparation, characterization and dynamical mechanical properties of dextran-coated iron oxide nanoparticles (DIONPs) , 2018, Artificial cells, nanomedicine, and biotechnology.

[21]  Ke Chen,et al.  Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings , 2018, Scientific Reports.

[22]  S. Tofail,et al.  Comprehensive cytotoxicity studies of superparamagnetic iron oxide nanoparticles , 2018, Biochemistry and biophysics reports.

[23]  M. Bonini,et al.  Switch of Mitochondrial Superoxide Dismutase into a Prooxidant Peroxidase in Manganese-Deficient Cells and Mice. , 2017, Cell chemical biology.

[24]  T. I. Ksenevich,et al.  Multiplex biosensing with highly sensitive magnetic nanoparticle quantification method , 2017, Journal of Magnetism and Magnetic Materials.

[25]  M. Soleymani,et al.  High impact of in situ dextran coating on biocompatibility, stability and magnetic properties of iron oxide nanoparticles. , 2017, Materials science & engineering. C, Materials for biological applications.

[26]  C. Burtea,et al.  Synthesis, Characterization, and Toxicity Evaluation of Dextran-Coated Iron Oxide Nanoparticles , 2017 .

[27]  Liza Merly,et al.  Murine RAW 264.7 cell line as an immune target: are we missing something? , 2017, Immunopharmacology and immunotoxicology.

[28]  R. Sanyal,et al.  "Clickable" Nanogels via Thermally Driven Self-Assembly of Polymers: Facile Access to Targeted Imaging Platforms using Thiol-Maleimide Conjugation. , 2017, Biomacromolecules.

[29]  F. Torti,et al.  Mitochondria and Iron: current questions , 2017, Expert review of hematology.

[30]  E. Madrigal-Santillán,et al.  A Master Regulator of Oxidative Stress - The Transcription Factor Nrf2 , 2016 .

[31]  J. Pérez,et al.  Endogenous Antioxidants: A Review of their Role in Oxidative Stress , 2016 .

[32]  P. Mohanan,et al.  Toxicological evaluation of dextran stabilized iron oxide nanoparticles in human peripheral blood lymphocytes. , 2016, Biointerphases.

[33]  D. F. Barber,et al.  Superparamagnetic iron oxide nanoparticle uptake alters M2 macrophage phenotype, iron metabolism, migration and invasion. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[34]  Sung Tae Kim,et al.  Regulation of Macrophage Recognition through the Interplay of Nanoparticle Surface Functionality and Protein Corona. , 2016, ACS nano.

[35]  P. MacEneaney,et al.  Pharmacokinetics and bio‐distribution of novel super paramagnetic iron oxide nanoparticles (SPIONs) in the anaesthetized pig , 2016, Clinical and experimental pharmacology & physiology.

[36]  S. Trépout,et al.  Titanium Dioxide Nanoparticles Increase Superoxide Anion Production by Acting on NADPH Oxidase , 2015, PloS one.

[37]  Binoy Bera Nanoporous Silicon Prepared by Vapour Phase Strain Etch and Sacrificial Technique , 2015 .

[38]  S. Awasthi,et al.  Antioxidant role of glutathione S-transferases: 4-Hydroxynonenal, a key molecule in stress-mediated signaling. , 2015, Toxicology and applied pharmacology.

[39]  R. Burlacu,et al.  Magnetite nanoparticles induced adaptive mechanisms counteract cell death in human pulmonary fibroblasts. , 2015, Toxicology in vitro : an international journal published in association with BIBRA.

[40]  W. V. D. Van de Ven,et al.  Dextran-coated superparamagnetic nanoparticles as potential cancer drug carriers in vivo. , 2015, Nanoscale.

[41]  Michael Iv,et al.  Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors. , 2015, Nanomedicine.

[42]  G. Bardi,et al.  Biomedical Nanoparticles: Overview of Their Surface Immune-Compatibility , 2014 .

[43]  R. Jayasree,et al.  Synthesis and characterization of dextran stabilized superparamagnetic iron oxide nanoparticles for in vivo MR imaging of liver fibrosis. , 2014, Carbohydrate polymers.

[44]  S. P. Clarke Development of Hierarchical Magnetic Nanocomposite Materials for Biomedical Applications , 2013 .

[45]  Albert Duschl,et al.  Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle , 2013, Journal of Nanobiotechnology.

[46]  M. Motelica-Heino,et al.  Magnetic Properties and Biological Activity Evaluation of Iron Oxide Nanoparticles , 2013 .

[47]  Ali Khademhosseini,et al.  Biocompatibility of engineered nanoparticles for drug delivery. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[48]  P. Mohanan,et al.  Dextran stabilized iron oxide nanoparticles: synthesis, characterization and in vitro studies. , 2013, Carbohydrate polymers.

[49]  J. Enghild,et al.  Hydrogen peroxide induce modifications of human extracellular superoxide dismutase that results in enzyme inhibition☆ , 2013, Redox biology.

[50]  A. Dinischiotu,et al.  Lipid peroxidation due to in vitro and in vivo exposure of biological samples to nanoparticles. , 2013, Methods in molecular biology.

[51]  K. S. Rajan,et al.  Temperature induced changes in ZnO–water nanofluid: Zeta potential, size distribution and viscosity profiles , 2012 .

[52]  M. Motelica-Heino,et al.  Synthesis and characterization of polysaccharide-maghemite composite nanoparticles and their antibacterial properties , 2012, Nanoscale Research Letters.

[53]  K. Lafdi,et al.  Biomedical properties and preparation of iron oxide-dextran nanostructures by MAPLE technique , 2012, Chemistry Central Journal.

[54]  D. S. St. Clair,et al.  Manganese Superoxide Dismutase: Guardian of the Powerhouse , 2011, International journal of molecular sciences.

[55]  Forrest M Kievit,et al.  Surface engineering of iron oxide nanoparticles for targeted cancer therapy. , 2011, Accounts of chemical research.

[56]  Ralph Weissleder,et al.  Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy. , 2011, Accounts of chemical research.

[57]  N. Dahl,et al.  Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia , 2011, American journal of hematology.

[58]  Piotr Walczak,et al.  Tracking stem cells using magnetic nanoparticles. , 2011, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[59]  Hua Ai,et al.  Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy. , 2011, Accounts of chemical research.

[60]  C. Galbán,et al.  Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting. , 2011, Biomaterials.

[61]  H. Arami,et al.  Chitosan-Coated Iron Oxide Nanoparticles for Molecular Imaging and Drug Delivery , 2011 .

[62]  Reuben T Chacko,et al.  Self-cross-linked polymer nanogels: a versatile nanoscopic drug delivery platform. , 2010, Journal of the American Chemical Society.

[63]  Mauro Ferrari,et al.  Enabling individualized therapy through nanotechnology. , 2010, Pharmacological research.

[64]  Zhichuan J. Xu,et al.  Synthesis, Functionalization, and Biomedical Applications of Multifunctional Magnetic Nanoparticles , 2010, Advanced materials.

[65]  O. Carp,et al.  Thermal analysis of two types of dextran-coated magnetite , 2010 .

[66]  Reuben T Chacko,et al.  Surface-functionalizable polymer nanogels with facile hydrophobic guest encapsulation capabilities. , 2010, Journal of the American Chemical Society.

[67]  R. Pazdur,et al.  FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease , 2010, American journal of hematology.

[68]  Ji-Ho Park,et al.  Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance. , 2009, Biomaterials.

[69]  Forrest M Kievit,et al.  PEI–PEG–Chitosan‐Copolymer‐Coated Iron Oxide Nanoparticles for Safe Gene Delivery: Synthesis, Complexation, and Transfection , 2009, Advanced functional materials.

[70]  C. Robic,et al.  Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. , 2008, Chemical reviews.

[71]  M. Costache,et al.  A STUDY ON IRON OXIDE NANOPARTICLES COATED WITH DEXTRIN OBTAINED BY COPRECIPITATION , 2007 .

[72]  C. Serna,et al.  Surface characterisation of dextran-coated iron oxide nanoparticles prepared by laser pyrolysis and coprecipitation , 2005 .

[73]  F. Petrat,et al.  Reduction of Fe(III) Ions Complexed to Physiological Ligands by Lipoyl Dehydrogenase and Other Flavoenzymes in Vitro , 2003, Journal of Biological Chemistry.

[74]  G. Schmuck,et al.  The influence of oxidative stress on catalase and MnSOD gene transcription in astrocytes , 2001, Brain Research.

[75]  J. Kehrer The Haber-Weiss reaction and mechanisms of toxicity. , 2000, Toxicology.

[76]  Ralph Weissleder,et al.  Long-circulating iron oxides for MR imaging , 1995 .

[77]  S E Seltzer,et al.  Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. , 1995, Radiology.

[78]  Y. Sugita,et al.  Kinetic studies on the removal of extracellular hydrogen peroxide by cultured fibroblasts. , 1994, The Journal of biological chemistry.

[79]  F. Paoletti,et al.  A sensitive spectrophotometric method for the determination of superoxide dismutase activity in tissue extracts. , 1986, Analytical biochemistry.

[80]  P. Kovacic Free Radicals in Biology and Medicine , 1986 .

[81]  B. Halliwell,et al.  Free radicals in biology and medicine , 1985 .

[82]  H. Aebi,et al.  Catalase in vitro. , 1984, Methods in enzymology.

[83]  I. Fridovich,et al.  Permeation of the erythrocyte stroma by superoxide radical. , 1978, The Journal of biological chemistry.

[84]  E. Beutler Red cell metabolism , 1971 .

[85]  V Miller,et al.  Medical-surgical nursing. , 1969, Arizona medicine.